Font size: A A A

SEMINARS - Description

Open Innovation and Intellectual Property Management in Health/Life Science

at University of Gothenburg, Gothenburg, Sweden


Intellectual property is often considered as an impediment to openness. While this may be true in some circumstances, it is increasingly becoming clear that intellectual property is a critical tool to govern open innovation. This seminar will explain the need for open innovation in the health/life science sector and provide examples of how intellectual property management can play a critical role in developing open innovation by facilitating both research collaborations and the utilization of research results. The goal of the seminar will be to show how health/life science firms, innovation systems actors and research groups can create greater value in their R&D activities through an intellectual property management approach to open innovation.

Learning Outcomes

The participants will learn to:

  • Identify opportunities where open innovation can support research and commercial goals
  • Recognize different types of open innovation models and degrees of openness
  • Understand the use of intellectual property as a means to govern openness
  • Understand the use of licensing and other contractual mechanisms to manage open innovation for development and commercialization
  • Identify background and foreground intellectual property in collaborative technology development


The seminar is organized by University of Gothenburg and Sahlgrenska School of Innovation and Entrepreneurship. The University of Gothenburg is one of the major universities in northern Europe and one of the most popular in Sweden, with approximately 37000 students and cutting-edge research in a number of knowledge areas. Health is a profile area rooted in the medical research at the Sahlgrenska Academy.

Sahlgrenska School of Innovation and Entrepreneurship at the University of Gothenburg, is a university initiative to gather all innovation and growth activities under one roof. It is a hub for research, education and collaboration in the field of innovation, entrepreneurship and intellectual property management.

Who should attend

The key audience is researchers, university innovation system persons, and industry actors that engage with universities. The participator should have an interest in health and life science.


1000 - 1015 Introduction to seminar
1015 - 1100 The Death of the Dinosaurs: The transformation of Big Pharma to open innovation
1100 - 1200 Open Innovation Platforms in Biomedicine: How are they open and why do they work?
1200 - 1300 Lunch
1300 - 1400 Innovative Medicine Initiative – Using open Innovation to build better, safer drugs faster
1400 - 1500 Case Study – Innovative Medicine Initiative at Astra Zeneca
1500 - 1530 Coffee break
1530 - 1630 University-Industry Collaboration in Biomedicine: The Johnson & Johnson Model
1630 - 1700 Discussion and Feedback

Registration is open until 21th of April.